EUVIMEDEUVIMED entdecken
Fallbericht

Remission of refractory Crohn's disease with anti‐ IL ‐12/23 therapy in a patient undergoing hemodialysis: A case report

Michail Spathakis iD, Eirini Filidou iD, George Kolios iD, Dimitrios Papazoglou iD, Stergios Vradelis

Hemodialysis International · 2023

DOI: 10.1111/hdi.13106 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hemodialysis International, 2023. Verfasst von Michail Spathakis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crohn's disease is a relapsing chronic inflammatory condition of the intestine with increasing prevalence around the world. Biologic therapies are currently widely used and have proved safe and effective in treating moderate to severe Crohn's disease. However, contemporary bibliography contains little information about the use of these drugs in patients with end‐stage renal disease undergoing hemodialysis. Here we present a case of a 47‐year‐old female patient with treatment‐refractory Crohn's disease on hemodialysis. In this patient, treatment with the anti‐IL‐12/23 receptor antibody ustekinumab was effective in inducing and maintaining remission while being safe in administering throughout hemodialysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseFemaleHumansMiddle AgedInterleukin-12Remission InductionRenal DialysisUstekinumabTreatment Outcome

Stichwörter der Autor:innen

Crohn's diseaseanti-IL-12/23case reporthemodialysisustekinumab

Substanzen

Interleukin-12Ustekinumab

Autor:innen und Institutionen

  • Laboratory of Pharmacology, Faculty of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
  • Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.

ORCID-Profile: Michail Spathakis, Eirini Filidou, George Kolios, Dimitrios Papazoglou

Zitieren

APA

Spathakis, M., Filidou, E., Kolios, G., Papazoglou, D., & Vradelis, S. (2023). Remission of refractory Crohn's disease with anti‐ IL ‐12/23 therapy in a patient undergoing hemodialysis: A case report. Hemodialysis International. https://doi.org/10.1111/hdi.13106

Vancouver

Spathakis M, Filidou E, Kolios G, Papazoglou D, Vradelis S. Remission of refractory Crohn's disease with anti‐ IL ‐12/23 therapy in a patient undergoing hemodialysis: A case report. Hemodialysis International. 2023. doi:10.1111/hdi.13106

BibTeX
@article{Spathakis2023,
  author = {Spathakis, Michail and Filidou, Eirini and Kolios, George and Papazoglou, Dimitrios and Vradelis, Stergios},
  title = {Remission of refractory Crohn's disease with anti‐ IL ‐12/23 therapy in a patient undergoing hemodialysis: A case report},
  journal = {Hemodialysis International},
  year = {2023},
  doi = {10.1111/hdi.13106}
}
Kostenlos starten →